Executives
-
Deasy Dana SCIDO, SVP IT & Data Analytics -
Schmidt Ann MSVP, Chief Com & Brand Officer
-
Cleary Michael JController
-
Mckenzie Howard EChief Engineer & EVP, ET&T
-
Pope Stephanie FEVP, Pres. & CEO, BCA and COO
-
Raymond David ChristopherEVP, Pres. & CEO, BGS
-
West BrianEVP & Chief Financial Officer
-
Ortberg Robert KellyPresident & CEO
-
Amuluru Uma MChief HR Officer
-
Besanceney Brian RCCO; SVP, Communications
-
Biegun Stephen ESVP, Global Public Policy
-
Calhoun David LPresident & CEO
-
D Ambrose MichaelCHRO, EVP, Human Resources
-
Deal Stanley AEVP, Pres. & CEO, BCA
-
Doniz SusanCIO & SVP, IT & Data Analytics
-
Gerry Brett C.CLO & EVP, Global Compliance
-
Nelson Brendan J.SVP, President, Boeing Intn'l
-
Ojakli Ziad SEVP, Gov't Ops
Board Directors
-
Soussan SabrinaDirector
-
Richardson John MDirector
-
Joyce David LeonDirector
-
Mollenkopf Steven MDirector
-
Johri AkhilDirector
-
Harris Stayce D.Director
-
Good Lynn JDirector
-
Gitlin David L.Director
-
Doughtie Lynne MDirector
-
Buckley Mortimer JDirector
-
Bradway Robert ADirector
-
Kellner Lawrence WDirector
-
Williams Ronald ADirector
?
Bradway Robert A
Director
The Boeing Company
US, Chicago [HQ]
CIK
1396482
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
661,795
Price per Share :
$272.03
Equivalence :
$180,028,093.85
Transaction History
-
F661,795 Shares After TransactionValue : $182,906,902.10$630,699.16Transaction Date : 04/30/24
-
Footnotes
-
-
Footnotes:#1 These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 4,143 RSUs which will vest on 5/5/2024; 4,516 RSUs which will vest on 4/30/2025; 13,781 RSUs which will vest in installments of 4,547 on 5/2/2024, 4,548 on 5/2/2025, and 4,686 on 5/2/2026; and 13,486 RSUs which will vest in two installments of 4,450 each on 5/2/2025 and 5/2/2026, and one installment of 4,586 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.#2 These shares include 2,419 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
-
F657,281 Shares After TransactionValue : $204,605,002.49$691,063.80Transaction Date : 05/05/24
-
Footnotes
-
-
Footnotes:#1 These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 4,516 RSUs which will vest on 4/30/2025; 9,234 RSUs which will vest in installments of 4,548 on 5/2/2025, and 4,686 on 5/2/2026; and 13,486 RSUs which will vest in two installments of 4,450 each on 5/2/2025 and 5/2/2026, and one installment of 4,586 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.#2 These shares include 1,555 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
-
G573,855 Shares After TransactionValue : $n/a$0.0Transaction Date : 12/02/24
-
Footnotes
-
-
Footnotes:#1 These shares were gifted by the reporting person and the reporting person's spouse to two irrevocable trusts for the benefit of the reporting person's children, subsequent to the same-day transfer by the reporting person of 48,000 shares as separate property of the reporting person's spouse. Neither the reporting person nor the reporting person's spouse are trustees of the children's trusts or otherwise have the power to vote or dispose of the assets held in such trusts.#2 Subsequent to the same-day transfer by the reporting person of 90,000 shares as separate property of the reporting person's spouse, such shares were contributed to a spousal grantor retained annuity trust of which the reporting person and the reporting person's spouse serve as trustees and the reporting person's spouse is the sole annuitant, resulting in indirect ownership by the reporting person of these shares.#3 Shares directly beneficially owned also include 2,141 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested restricted stock units (RSUs) and are paid out in shares of the Company's common stock on a one-to-one basis upon vesting of the associated RSUs with a cash payment for any remaining fractional share amount.
-
G90,000 Shares After TransactionValue : $n/a$0.0Transaction Date : 12/02/24
-
Footnotes
-
-
Footnotes:#1 These shares were gifted by the reporting person and the reporting person's spouse to two irrevocable trusts for the benefit of the reporting person's children, subsequent to the same-day transfer by the reporting person of 48,000 shares as separate property of the reporting person's spouse. Neither the reporting person nor the reporting person's spouse are trustees of the children's trusts or otherwise have the power to vote or dispose of the assets held in such trusts.#2 Subsequent to the same-day transfer by the reporting person of 90,000 shares as separate property of the reporting person's spouse, such shares were contributed to a spousal grantor retained annuity trust of which the reporting person and the reporting person's spouse serve as trustees and the reporting person's spouse is the sole annuitant, resulting in indirect ownership by the reporting person of these shares.#3 Shares directly beneficially owned also include 2,141 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested restricted stock units (RSUs) and are paid out in shares of the Company's common stock on a one-to-one basis upon vesting of the associated RSUs with a cash payment for any remaining fractional share amount.
-
G393,855 Shares After TransactionValue : $n/a$0.0Transaction Date : 12/02/24
-
Footnotes
-
-
Footnotes:#1 These shares were gifted by the reporting person and the reporting person's spouse to two irrevocable trusts for the benefit of the reporting person's children, subsequent to the same-day transfer by the reporting person of 48,000 shares as separate property of the reporting person's spouse. Neither the reporting person nor the reporting person's spouse are trustees of the children's trusts or otherwise have the power to vote or dispose of the assets held in such trusts.#2 Subsequent to the same-day transfer by the reporting person of 90,000 shares as separate property of the reporting person's spouse, such shares were contributed to a spousal grantor retained annuity trust of which the reporting person and the reporting person's spouse serve as trustees and the reporting person's spouse is the sole annuitant, resulting in indirect ownership by the reporting person of these shares.#3 Shares directly beneficially owned also include 2,141 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested restricted stock units (RSUs) and are paid out in shares of the Company's common stock on a one-to-one basis upon vesting of the associated RSUs with a cash payment for any remaining fractional share amount.